Skip to content

Total value of intensive exercise training (three weeks) immediately after hospital discharge for arthritis patients due to a flare of disease activity or for elective joint replacements

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN24488371
Enrollment
130
Registered
2007-01-16
Start date
2002-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis and Osteoarthritis Musculoskeletal Diseases Arthropathies

Interventions

Directly following hospital discharge the patients of this study design recieved Intensive Exercise Therapy (IET) or Usual Care (UC). The IET group were referred to a dedicated convalescent ?hotel?.

Sponsors

University of Twente (The Netherlands)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged over 18 2. Rheumatoid Arthritis (RA) according to the American College of Rheumatology (ACR) 1987 or polyarticular OsteoArthritis (OA)

Exclusion criteria

Exclusion criteria: 1. Presence of serious cardiac disease (New York Heart Association [NYHA] class III and IV) 2. Incapacitating pulmonary disease Global initiative for chronic Obstructive Lung Disease (GOLD) stage IV 3. Serious hypertension (diastolic blood pressure more than 110 mmHg) 4. Pregnancy 5. Insufficient understanding of the Dutch language 6. Functional incapacity (Steinbrocker functional class four)

Design outcomes

Primary

MeasureTime frame
Function ability as measured with the McMaster Toronto Arthritis patient preference questionnaire (MACTAR) and Health Assessment Questionnaire (HAQ).

Secondary

MeasureTime frame
1. Quality of life as measured with the RAND-36/Short Form health survey (SF-36) and Arthritis Impact Measurement Scales (AIMS) 2. Mobility as measured with the Escola Paulista de Medicina Range Of Motion (EPM-ROM) 3. Pain, general health as measured with a Visual Analogue Scale 4. Costs

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026